- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/708 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
Patent holdings for IPC class A61K 31/708
Total number of patents in this class: 471
10-year publication summary
|
33
|
37
|
43
|
34
|
30
|
43
|
36
|
27
|
30
|
18
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Alios BioPharma, Inc. | 65 |
20 |
| Idenix Pharmaceuticals LLC | 62 |
12 |
| Centre National de La Recherche Scientifique | 10498 |
10 |
| Gilead Sciences, Inc. | 2042 |
9 |
| The Board of Regents of the University of Texas System | 2216 |
9 |
| Stagen Co., Ltd. | 15 |
8 |
| Merck Sharp & Dohme LLC | 3750 |
8 |
| The Trustees of Columbia University in the City of New York | 3584 |
7 |
| Atea Pharmaceuticals, Inc. | 76 |
7 |
| Janssen Pharmaceuticals, Inc. | 435 |
6 |
| Abbott Laboratories | 2397 |
6 |
| Dana-Farber Cancer Institute, Inc. | 2577 |
5 |
| Idenix Pharmaceuticals, Inc. | 45 |
5 |
| Ligand Pharmaceuticals Incorporated | 171 |
5 |
| UCB BioSciences, Inc. | 34 |
5 |
| Janssen Biopharma, Inc. | 40 |
5 |
| President and Fellows of Harvard College | 5992 |
4 |
| Chen Yusong | 11 |
4 |
| N.V. Nutricia | 1063 |
4 |
| Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | 1347 |
4 |
| Other owners | 328 |